Navigation Links
World Renowned Scientists Gather to Share Latest Information on Answer to Wildlife Reproductive Fertility Control
Date:7/24/2009

FLAGSTAFF, Ariz., July 24 /PRNewswire/ -- Scientists from the United States and other nations including Canada, Australia, New Zealand, Great Britain, Myanmar, the Philippines and Indonesia are meeting Saturday through Wednesday, July 25 through 29, 2009 at Flagstaff's Radisson Woodlands Hotel to share research findings that will determine the future emphasis for humane animal population management worldwide.

On Sunday morning, Mayor Sara Presler will welcome those in attendance to Flagstaff, the city of innovation, where SenesTech was founded in 2002 by Drs. Loretta Mayer and Cheryl Dyer. Along with Dr. Lyn Hinds, the Senior Principal Research Scientist of the Australian Commonwealth Scientific and Industrial Research Organisation (CSIRO) and other prominent guests, Drs. Mayer and Dyer will present and lead group sessions through the Chemical Acceleration of Ovarian Senescence symposium, which will end Wednesday in a plenary session that will determine the research goals for the coming year.

SenesTech is grateful to the City of Flagstaff, Arizona for its support during the past seven years. "The City of Flagstaff, through its incubator program at the Northern Arizona Center for Emerging Technologies has allowed us to follow the Arizona Biotechnology Road Map from the Arizona universities to technology transfer and onto the road to commercialization" said Everett Hale, CEO for SenesTech. "The partnerships SenesTech has formed throughout the globe have helped this exciting technology reach countries that are in desperate need of a solution to rodent population management to provide sustainable food supplies to millions."

The company is currently applying their revolutionary technology to the control of the Southeast Asian rice rat in order to increase rice production. It is projected that the application of SenesTech's product, ContraPest, will result in food for at least an additional 380 million people annually within three years. In addition, SenesTech is also developing a product called ChemSpay that will address the management of the overpopulation of homeless companion pets, as well as, feral dogs and cats. People in places like India and Russia die from bites by feral rabid animals every thirty seconds and currently use poison to control those feral populations. "ChemSpay is a more humane and sensible way to manage these populations without killing," said Dr. Loretta Mayer, Chief Scientific Officer for SenesTech.

SenesTech is a platform biotechnology company headquartered in Flagstaff, Arizona and specializes in humane animal population management.


'/>"/>
SOURCE SenesTech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Prof. Mario Tredici Shared Views on Algae Projects with Algae Business Players at Algae World!
2. avVaa World Health Care Products Inc. Announces Web Site Design for Neuroskin(R) Psoriasis Relief DRTV Campaign
3. New Scientific Worldview Biocentrism Featured in The Huffington Post - #1 Weblog in the World
4. BioNeutrals Ygiene(TM) Hospital Grade Achieves World Class Independent Test Results in Killing Life Threatening Spores/Organisms
5. Material world: Graphenes versatility promises new applications
6. Enerkem Announces World-Class Advanced Energy Research Center in Edmonton, Alberta, Canada
7. New Report Just Published: World Prostate Cancer Therapeutics Market Report
8. New Report Just Published: World Endoscopy Systems Market Report
9. Celebrities to Gather to Support the Ninth Annual Starkey Hearing Foundation So the World May Hear Awards Gala
10. Essilor: Essilor Forges New Strategic Partnerships Around the World
11. avVaa World Health Care Products, Inc. Signs Agreement with 3PL Worldwide, Inc., for Order Management & Fulfillment for avVaas Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in ... Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio ... practical tips, tools, and strategies for clinical researchers. , “The landscape of how ...
Breaking Biology Technology:
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
Breaking Biology News(10 mins):